HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorUniversity of Modena and Reggio Emilia

About this trial

This pilot, multicenter, interventional study investigates the expression of HOXB7 and its associated molecular pathway in lung tissue and blood-derived exosomes from patients with pulmonary fibrosis (PF), including idiopathic pulmonary fibrosis (IPF). Using RNA sequencing (RNA-Seq) and proteomic analysis via mass spectrometry (MS), the study aims to identify tissue and circulating biomarkers associated with fibrosis progression. The study compares different biopsy techniques (surgical vs. transbronchial cryobiopsy) and also includes a control group of patients undergoing lung resection for non-fibrotic conditions.

Eligibility criteria

Qualifiers

Adults aged 18 to 80 with clinical suspicion of pulmonary fibrosis

Availability of fresh lung tissue from biopsy or lung explant

Signed informed consent for research use of biological material and data

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Biopsy

Treatment groups

80 Participants
are divided into 2 treatment groups